These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5619049)

  • 1. [Clinical results obtained with a new hypotensive agent (2156 TH)].
    Bansillon M; Traeger J
    J Med Lyon; 1967 Jul; 48(124):1129-38. PubMed ID: 5619049
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of a hypotensive association: TH 2156].
    Warembourg H; Stalnikiewicz G
    Lille Med; 1966 Apr; 11(4):498-501. PubMed ID: 5932313
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of a new hypotensive agent, TH 2,156].
    Sudre Y; Bernadou M; Hébert A
    J Med Bord; 1966 Mar; 143(3):383-9. PubMed ID: 4379551
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic trial of a new hypotensive agent, Th 2156. Its place in the medical treatment of arterial hypertension].
    Pierron J
    Mars Med; 1966; 103(2):133-7. PubMed ID: 5908585
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term effects of endralazine (BQ-22-708) in patients with renal impairment and hypertension.
    Kingswood JC; Harrison PR; Banks RA; Higgs E; Mackenzie JC
    Postgrad Med J; 1983; 59 Suppl 3():173-6. PubMed ID: 6647204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of a drug with double vascular action in permanent arterial hypertension].
    Witchitz S; Chiche P
    Cah Coll Med Hop Paris; 1966 May; 7(5):331-5. PubMed ID: 5941233
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of the ganglionic blocking agent pyrilene together with other hypotensive agents].
    Tikhonenko VM; Kazak LI
    Vrach Delo; 1973 Mar; 3():19-21. PubMed ID: 4733020
    [No Abstract]   [Full Text] [Related]  

  • 8. [Catapresan--a new hypotensive agent].
    Tarkowska A
    Pol Tyg Lek; 1969 Jun; 24(24):934-6. PubMed ID: 4896410
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative clinical evaluation of the effectiveness and tolerance of a new antihypertensive agent, DL 150 IT, administered alone and in combination with reserpine or propranolol].
    Glorioso S; Romeo B; Borsatti A; Todesco S
    Clin Ter; 1977 Nov; 83(3):279-99. PubMed ID: 603983
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of a new hypotensive drug combination].
    Castillo Higueras PL; Rodríguez Cuartero A; Rodríguez Cuartero F; Urbano Jiménez F; Peláez Redondo J
    Rev Clin Esp; 1977 Oct; 147(2):185-9. PubMed ID: 601282
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical pharmacology of a new hypotensive drug with peripheral vasodilating action (ISF 2123); effects of acute intravenous administration in hypertensive patients].
    Terzoli L; Bianchini C; Cornelli U; Sala C; Leonetti G; Zanchetti A
    Boll Soc Ital Cardiol; 1977; 22(7):1053-6. PubMed ID: 618241
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of pirilen, dimecolin and isobarin on certain clinico-biochemical indicators in patients with hypertensive disease].
    Shcherbak VV
    Vrach Delo; 1973 Aug; 8():72-4. PubMed ID: 4149201
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic examination and studies on renal function with a new antihypertensive agent (St 155)].
    Frank H; von Loewenich-Lagois K
    Dtsch Med Wochenschr; 1966 Sep; 91(38):1680-6. PubMed ID: 5917870
    [No Abstract]   [Full Text] [Related]  

  • 14. [First clinical experiences with a new hypotensive substance in severe forms of hypertension].
    Bergström J; Bergquist-Poppen M; Bucht H
    Arzneimittelforschung; 1966 Dec; 16(12):1606-10. PubMed ID: 6014792
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with a new antihypertensive agent].
    Lieb W; Ridders K
    Arzneimittelforschung; 1966 Dec; 16(12):1610-5. PubMed ID: 6014793
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endralazine in the treatment of hypertension].
    Fet'kovská N; Tison P
    Vnitr Lek; 1984 Feb; 30(2):163-8. PubMed ID: 6372236
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with a new hypotensive substance].
    Kühns K; Janocha U; Janocha C; Magnus D
    Munch Med Wochenschr; 1965 Dec; 107(51):2599-602. PubMed ID: 5331065
    [No Abstract]   [Full Text] [Related]  

  • 18. [Debrisoquine sulfate, a new antihypertensive agent].
    Dieu Y
    Brux Med; 1970 Mar; 50(3):195-201. PubMed ID: 5446621
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative assessment of the results of new antihypertensive drugs].
    Schubert R; Pasz T; Lindner O
    Munch Med Wochenschr; 1968 Jul; 110(27):1604-9. PubMed ID: 5756285
    [No Abstract]   [Full Text] [Related]  

  • 20. Fourteen-year survival in a case of malignant hypertension under hypotensive drug therapy.
    Pomerantz HZ
    Can Med Assoc J; 1968 Nov; 99(21):1043-7. PubMed ID: 5721944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.